Here’s Why Conestoga Capital Advisors Decided to Sell Simulations Plus (SLP)
Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Simulations Plus Inc. (SLP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 352,585 | $5,313,455 | +181% | 0% |
| 2. | Royce & Associates Chuck Royce | 348,758 | $5,255,783 | +32% | 0.05% |
| 3. | Sio Capital Michael Castor | 320,307 | $4,827,026 | 1.22% | |
| 4. | Millennium Management Israel Englander | 306,020 | $4,611,721 | -45% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 250,482 | $3,774,764 | +88% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $58.16 | 24,000 | $1,395,840.00 | 4,755,309 | 2020-08-26 | Filing | |
| $1.13 | 3,000 | $3,390.00 | 13,000 | 2009-05-15 | Filing | |
| $1.10 | 2,000 | $2,200.00 | 10,000 | 2009-05-14 | Filing | |
| $1.08 | 4,000 | $4,320.00 | 8,000 | 2009-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.39 | 20,000 | $307,800.00 | 3,286,231 | 2025-10-01 | Filing | |
| $14.10 | 867 | $12,224.70 | 9,063 | 2025-09-02 | Filing | |
| $12.93 | 867 | $11,210.31 | 9,930 | 2025-08-01 | Filing | |
| $18.58 | 12,224 | $227,121.92 | 3,304,157 | 2025-07-01 | Filing | |
| $17.94 | 7,776 | $139,501.44 | 3,316,381 | 2025-07-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,297,423 | $19,552,165 | 0% | |
| 2. | 1,224,990 | $18,460,600 | 0% | |
| 3. | 1,136,980 | $17,134,276 | 0.81% | |
| 4. | 974,484 | $14,685,474 | 0% | |
| 5. | 767,760 | $11,570,143 | 1.09% |
News See All
Simulations Plus (SLP) AI-Driven Drug Design Collaboration Yields Positive Results
Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts.
Top 10 Medical AI Companies to Buy According to Analysts
Artificial intelligence is transforming medical sciences in ways not seen before.
Conestoga Capital Advisors Trimmed Its Position in Simulations Plus (SLP)
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
KeyBanc Downgrades Simulations Plus (SLP) Stock to Sector Weight
Simulations Plus, Inc. (NASDAQ:SLP) is one of the Best Beaten Down Stocks to Buy Now.
11 Best Beaten Down Stocks to Buy Now
J.P. Morgan Research believes that the S&P 500 will close near 6,000 by year-end, aided by the double-digit growth in earnings.
Simulations Plus, Inc. (NASDAQ:SLP) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Simulations Plus Third Quarter Fiscal 2025 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Craig-Hallum Trims Simulations (SLP) Price Target, Maintaining a Buy Rating
Simulations Plus, Inc.
Top 10 Healthcare AI Stocks to Buy According to Hedge Funds
“Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s reverberating across Wall Street.
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Simulations Plus Second Quarter Fiscal 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.